Who owns Cumberland Pharmaceuticals?

Tip: Access positions for across all investors

Analyze quarterly positions in Cumberland Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Cumberland Pharmaceuticals stock

Who bought or sold Cumberland Pharmaceuticals this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 374k $671k 0% Dec 2023
 View chart
Dimensional Fund Advisors 366k $637k -4% Dec 2023
 View chart
Bank of New York Mellon 75k $127k 0% Mar 2024
 View chart
Citadel Advisors 50k $87k 11% Dec 2023
 View chart
Two Sigma Investments 33k $59k -1% Dec 2023
 View chart
Two Sigma Advisers 23k $42k -1% Dec 2023
 View chart
Oakworth Capital 3.1k $5.1k 0% Mar 2024
 View chart
Royal Bank of Canada 138.00 $0 -7% Dec 2023
 View chart
UBS Group 110.00 $196.999000 100% Dec 2023
 View chart
Wells Fargo & Company 63.00 $113.003100 3% Dec 2023
 View chart
Jpmorgan Chase & Co 12.00 $21.000000 20% Dec 2023
 View chart
Bank of America Corporation 5.00 $9.000000 100% Dec 2023
 View chart
Huntington National Bank 1.00 $2.000000 0% Dec 2023
 View chart

Who sold out of Cumberland Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Wiley Bros.-aintree Capital Dec 2023 11k $20k
Simplex Trading Dec 2023 237.00 $0